Regadenoson

SKU: orb1305186

Description

Regadenoson (CVT-3146) is a selective A2A adenosine receptor agonist used as a coronary vasodilator in pharmacological stress testing. Its high selectivity and longer half-life compared to adenosine make it valuable for myocardial perfusion imaging in clinical and preclinical research, including studies of coronary flow reserve.

Research Area

Pharmacology & Drug Discovery

Key Properties

• CAS Number: 313348-27-5
• MW: 390.35
• Purity: >99.99% (May vary between batches)
• Formula: C₁₅H₁₈N₈O₅
• SMILES: CNC(=O)c1cnn(c1)-c1nc(N)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1
• Target: Adenosine Receptor
• Solubility: 10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (2.56 mM);DMSO:255 mg/mL (653.26 mM)

Bioactivity

• Target IC50:
  A2A receptor:290 nM(Ki)

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Regadenoson, P1 receptor, myocardial perfusion imaging, inhibit, Inhibitor, Lexiscan, Adenosine Receptor, AdenosineReceptor, A2A, CBF, BBB, coronary, CVT3146, CVT-3146, CVT 3146

Compound Identifiers

PubChem CID

219024